SMARCA2 and neoplasm: In order to address whether the tumor growth inhibition observed in SMARCA4mut models was due to a tumor cell autonomous effect of SMARCA2 degradation, we evaluated A947 administration in the SMARCA4wt Calu-6 xenograft model (Fig. 4f).